FFPE target discovery
Custom biospecimen sourcing
Target identification & ranking
Target expression profiling
Data generation
AI-ready Spatial Biology Datasets
Across Visium, Xenium, Chromium
Emerging IO Targets: pipeline overview
Functional efficacy and MoA
Tumor killing assays
Direct · ADCC · T-cell · Antigen-specific
Immune function & modulation
Activation · Migration · MLR · Macrophage Polarization · Germinal Center Reaction
Safety & Immunogenicity
Cytokine release
Additional capabilities
Patient-Derived 3D tumor models
Immune-native organoids · Tumor fragments
Modality-specific assays
ADCs · T-cell engagers · Cancer vaccines
Xenium for cells
Biomarker analysis
Transcriptomic biomarkers
Spatial transcriptomics · scRNAseq
ISO-certified pathology services
IHC/IF assay development · Assay validation · TLS scoring
Peripheral biomarkers
Proteomics · Flow cytometry · scRNAseq
Certified IHC/IF biomarker services
Clinical-grade quality management
Read announcement →
10x Genomics-Certified Services
Chromium X, Visium HD, Xenium
Publications
Case studies
Posters & abstracts
IO Target Database
Events & webinars
News & press
Company
Commitments
Careers
Placeholder content for Modality-Specific Oncology Assays. Replace with Elementor.
